Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
j6EfC44v95XgLZun